{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Why is Genpharmasec falling/rising?
On 04-Dec, Genpharmasec Ltd’s stock price continued its downward trajectory, closing at ₹1.43, down 3.38% from the previous session. This decline reflects a sustained period of underperformance relative to both its sector and broader market benchmarks.
Genpharmasec Stock Falls to 52-Week Low of Rs.1.41 Amidst Prolonged Downtrend
Genpharmasec has reached a new 52-week low of Rs.1.41, marking a significant decline in its share price amid a challenging market environment and subdued financial performance over the past year.
Why is Genpharmasec falling/rising?
As of 13-Nov, Genpharmasec Ltd's stock price is 1.55, up 4.03% recently, but it has declined significantly over the year by nearly 50%. Despite short-term gains, the overall trend remains negative, indicating investor caution.
Why is Genpharmasec falling/rising?
As of 11-Nov, Genpharmasec Ltd's stock price is Rs. 1.44, down 4.0% and at a 52-week low. The stock has significantly underperformed its sector and the broader market, with a year-to-date decline of 53.40%.
Genpharmasec Stock Plummets to New 52-Week Low of Rs. 1.47
Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a significant decline over the past year. Despite reporting positive quarterly results, the company's long-term fundamentals remain weak, with challenges in debt servicing and consistent underperformance compared to the broader market.
Genpharmasec Q2 FY26: Profit Surge Masks Deteriorating Fundamentals
Genpharmasec Ltd., a micro-cap trading and distribution company, reported a net profit of ₹1.22 crores for Q2 FY26, marking a dramatic 269.70% year-on-year surge from ₹0.33 crores in Q2 FY25. However, this headline figure conceals a troubling sequential decline, with profits plunging 551.85% quarter-on-quarter from a loss of ₹0.27 crores in Q1 FY26. The company's shares, currently trading at ₹1.52, have collapsed 50.97% over the past year, reflecting deep-seated investor concerns about the sustainability of its business model and deteriorating financial health.
Genpharmasec Hits New 52-Week Low at Rs. 1.5 Amid Market Decline
Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a 50% decline over the past year. Despite a recent performance improvement, the stock struggles below key moving averages and faces challenges with long-term financial strength and debt servicing capabilities, despite a notable increase in net sales.
How has been the historical performance of Genpharmasec?
Genpharmasec has experienced steady revenue growth from 25.52 Cr in Mar'23 to 33.72 Cr in Mar'25, but operating profit has fluctuated, with a recovery in profit after tax from a loss in Mar'24 to 1.23 Cr in Mar'25. The company faces challenges in managing expenses and cash flow despite overall growth.
Why is Genpharmasec falling/rising?
As of 06-Nov, Genpharmasec Ltd's stock price is Rs. 1.52, down 3.18% and at a 52-week low. The stock has declined 14.61% over the past five days and is underperforming significantly compared to the Sensex, with a year-to-date return down 50.81%.
Genpharmasec Stock Plummets to New 52-Week Low at Rs. 1.54
Genpharmasec has reached a new 52-week low, marking a significant downturn after a five-day decline. The stock is trading below multiple moving averages and has underperformed over the past year. Despite a substantial increase in operating profit, long-term fundamentals and debt servicing capabilities raise concerns.
Genpharmasec Stock Hits New 52-Week Low at Rs. 1.57
Genpharmasec, a microcap in the Trading & Distributors sector, has reached a new 52-week low, reflecting a challenging year with a significant decline in stock performance. Despite outperforming its sector recently, the stock remains below key moving averages, indicating ongoing struggles in profitability and long-term performance.
Why is Genpharmasec falling/rising?
As of 31-Oct, Genpharmasec Ltd's stock price is Rs 1.61, down 3.59%, with a significant decline of 47.90% year-to-date. Despite increased investor participation, the stock is underperforming compared to the Sensex, indicating waning investor confidence.
Genpharmasec Hits New 52-Week Low as Stock Plummets to Rs. 1.58
Genpharmasec has reached a new 52-week low, reflecting ongoing struggles in the Trading & Distributors sector. The company has faced significant challenges over the past year, with a notable decline in stock performance and weak long-term financial metrics, raising concerns about its market position and debt servicing capabilities.
Genpharmasec Stock Plummets to New 52-Week Low at Rs. 1.6
Genpharmasec has hit a new 52-week low, reflecting a significant downturn after two days of gains. The stock is trading below key moving averages and has declined 43.65% over the past year. Weak long-term fundamentals and concerns about debt servicing further complicate its market position.
Why is Genpharmasec falling/rising?
As of 08-Oct, Genpharmasec Ltd's stock price is Rs. 1.78, unchanged, and has hit a 52-week low of Rs. 1.72, reflecting a downward trend with a 5.82% decline over the past week and a 42.39% drop year-to-date. The stock is underperforming compared to the broader market, which has seen gains, and is trading below key moving averages, indicating ongoing weakness.
Genpharmasec Hits 52-Week Low of Rs. 1.72 Amid Market Decline
Genpharmasec, a microcap in the Trading & Distributors sector, has hit a new 52-week low of Rs. 1.72. The stock has declined 38.83% year-to-date, underperforming against the Sensex. Financial metrics reveal challenges, including a negative EBIT to Interest ratio and low Return on Equity, raising concerns about its viability.
Genpharmasec Hits New 52-Week Low at Rs. 1.79 Amid Market Gains
Genpharmasec has hit a new 52-week low, reflecting a significant decline in its stock price over the past year, contrasting with the overall market's performance. Despite a sharp increase in operating profits recently, the company's long-term fundamentals and debt servicing capabilities raise concerns about its financial health.
Why is Genpharmasec falling/rising?
As of 06-Oct, Genpharmasec Ltd's stock price is Rs. 1.88, showing a slight increase but remains below all moving averages, indicating a bearish trend. The stock has underperformed the Sensex and hit a new 52-week low, reflecting ongoing challenges in attracting investor confidence.
Why is Genpharmasec falling/rising?
As of 24-Sep, Genpharmasec Ltd's stock price is 1.98, down 1.0% and has underperformed its sector. Despite a significant increase in operating profit, the stock faces long-term financial challenges and has consistently underperformed against the benchmark, indicating a lack of investor confidence.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
